ClearPoint Neuro, Inc. Cash and Restricted Cash
ClearPoint Neuro, Inc. (CLPT) had Cash and Restricted Cash of $30.29 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-03
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.29M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $36.52M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46.97M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $38.40M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $30.29M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $36.52M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $46.97M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $38.40M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $41.72M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $12.39M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $20.10M 10-Q · filed 2026-08-03 |
| 2024-09-30 | $21.57M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $32.84M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $35.35M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $23.14M 10-K · filed 2026-03-17 |
| 2023-09-30 | $24.34M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $26.46M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $21.79M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $27.61M 10-K · filed 2025-02-26 |
| 2022-09-30 | $18.71M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $23.52M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $49.66M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $54.11M 10-K · filed 2024-03-12 |
| 2021-09-30 | $57.65M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $61.52M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $64.86M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $20.10M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |